Reference - RRC(Research Resource Circulation)

Species	Resource	RRC ID	Title	Journal	Published	Link
General Microbes	JCM13569 , JCM15300 , JCM15297	88930	Combined dual β-lactams and diazabicyclooctane β-lactamase inhibitor is highly effective against Mycobacterium abscessus species in vitro.	J Glob Antimicrob Resist	2025-5-1	Pubmed Full text
Human and Animal Cells	Ba/F3(RCB0805)	75789	Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.	Cancer Discov	2016-10-1	Pubmed Full text
Human and Animal Cells	Ba/F3	74819	NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations.	Cancer Discov	2023-3-1	Pubmed Full text
Human and Animal Cells	Ba/F3(RCB0805)	71806	Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer.	Nat Cancer	2022-6-1	Pubmed Full text
Human and Animal Cells	Ba/F3	66954	Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer.	Cancer Discov	2018-6-1	Pubmed Full text
Human and Animal Cells	Ba/F3	58004	The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models.	Nat Commun	2019-8-9	Pubmed Full text

Reference - List